C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways

A recent phase I clinical trial (SCIPIO) has shown that autologous c-kit+ cardiac progenitor cells (CPCs) improve cardiac function and quality of life when transplanted into patients with ischemic heart disease. Although c-kit is widely used as a marker of resident CPCs, its role in the regulation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Vajravelu, Bathri N., Hong, Kyung U., Al-Maqtari, Tareq, Cao, Pengxiao, Keith, Matthew C. L., Wysoczynski, Marcin, Zhao, John, Moore IV, Joseph B., Bolli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608800/
https://www.ncbi.nlm.nih.gov/pubmed/26474484
http://dx.doi.org/10.1371/journal.pone.0140798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4608800/
https://www.ncbi.nlm.nih.gov/pubmed/26474484
http://dx.doi.org/10.1371/journal.pone.0140798

Ejemplares similares